Bashan Dror 4
4 · Protalix BioTherapeutics, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2022-02-25+637,531→ 1,085,458 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.